Community Outreach and Engagement ABSTRACT The City of Hope Comprehensive Cancer Center (COHCCC) is a freestanding cancer center whose main campus is located in Duarte, California. The COHCCC Catchment Area includes the entirety of Los Angeles and Orange Counties and portions of Ventura, Riverside, and San Bernardino Counties. The Catchment Area is bounded by the Pacific Ocean to the south and west; Antelope Valley to the north; Santa Clarita and Simi Valley to the west; the metropolitan areas of Riverside and San Bernardino to the east; and the communities of Palm Desert, Murrieta, and San Clemente to the south. The COHCCC Catchment Area covers 9,365 square miles and includes the heart of the greater Los Angeles metropolitan area and more inland communities. We serve a multi-racial, multi-ethnic community of over 17.1 million individuals, which represents approximately 40 percent of all Californians. Remarkably, the population of our Catchment Area is greater than the individual populations of 46 states and greater than the populations of 14 states combined. The COHCCC seeks to use its research and resources to improve the lives of the men, women, and children who live in our Catchment Area, particularly in the more inland regions. The residents we serve face challenges that impact cancer survival, including poverty, obesity, and lack of access. These challenges are uniformly faced whether an individual comes from urban or more rural environments. To achieve this goal, COHCCC has three themes: 1. Identify and pursue challenging questions in cancer research relevant to the people of our Catchment Area. 2. Develop and implement strategies for including underserved populations in our programmatic research. 3. Take advantage of research discoveries, collaborations, networks, and affiliates to extend our reach and to implement creative interventions to increase access and health equity within our Catchment Area, as well as nationally and internationally. To reduce the incidence of cancer in the unique populations we serve within our Catchment Area, we identified the following priorities: ? Biologically aggressive cancers that impact diverse populations in our COHCCC Catchment Area ? Viral-related cancers, including hepatocellular carcinoma and HIV-related malignancies ? Impact of pollution on cancer incidence, with a focus on breast and lung cancer ? Cancers of aging in Asian- and Latino-Americans

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA033572-38
Application #
10059212
Study Section
Subcommittee I - Transistion to Independence (NCI)
Program Officer
Roberson, Sonya
Project Start
1997-08-01
Project End
2022-11-30
Budget Start
2020-12-01
Budget End
2021-11-30
Support Year
38
Fiscal Year
2021
Total Cost
Indirect Cost
Name
Beckman Research Institute/City of Hope
Department
Type
DUNS #
027176833
City
Duarte
State
CA
Country
United States
Zip Code
91010
Gast, Charles E; Silk, Alain D; Zarour, Luai et al. (2018) Cell fusion potentiates tumor heterogeneity and reveals circulating hybrid cells that correlate with stage and survival. Sci Adv 4:eaat7828
Salgia, Ravi; Kulkarni, Prakash (2018) The Genetic/Non-genetic Duality of Drug 'Resistance' in Cancer. Trends Cancer 4:110-118
Yoon, Sorah; Wu, Xiwei; Armstrong, Brian et al. (2018) An RNA Aptamer Targeting the Receptor Tyrosine Kinase PDGFR? Induces Anti-tumor Effects through STAT3 and p53 in Glioblastoma. Mol Ther Nucleic Acids 14:131-141
Yim, John H; Choi, Audrey H; Li, Arthur X et al. (2018) Identification of Tissue-Specific DNA Methylation Signatures for Thyroid Nodule Diagnostics. Clin Cancer Res :
Wang, Tianyi; Fahrmann, Johannes Francois; Lee, Heehyoung et al. (2018) JAK/STAT3-Regulated Fatty Acid ?-Oxidation Is Critical for Breast Cancer Stem Cell Self-Renewal and Chemoresistance. Cell Metab 27:136-150.e5
Magilnick, Nathaniel; Boldin, Mark P (2018) Molecular Moirai: Long Noncoding RNA Mediators of HSC Fate. Curr Stem Cell Rep 4:158-165
Yun, Xinwei; Zhang, Keqiang; Wang, Jinhui et al. (2018) Targeting USP22 Suppresses Tumorigenicity and Enhances Cisplatin Sensitivity Through ALDH1A3 Downregulation in Cancer-Initiating Cells from Lung Adenocarcinoma. Mol Cancer Res 16:1161-1171
Herrera, Alex F; Rodig, Scott J; Song, Joo Y et al. (2018) Outcomes after Allogeneic Stem Cell Transplantation in Patients with Double-Hit and Double-Expressor Lymphoma. Biol Blood Marrow Transplant 24:514-520
Slavin, Thomas P; Banks, Kimberly C; Chudova, Darya et al. (2018) Identification of Incidental Germline Mutations in Patients With Advanced Solid Tumors Who Underwent Cell-Free Circulating Tumor DNA Sequencing. J Clin Oncol :JCO1800328
Shahin, Sophia A; Wang, Ruining; Simargi, Shirleen I et al. (2018) Hyaluronic acid conjugated nanoparticle delivery of siRNA against TWIST reduces tumor burden and enhances sensitivity to cisplatin in ovarian cancer. Nanomedicine 14:1381-1394

Showing the most recent 10 out of 1396 publications